What is the appropriate evaluation and management for a 26‑year‑old woman with an elevated total testosterone level of 72 ng/dL?

Evaluation and Management of Elevated Testosterone (72 ng/dL) in a 26-Year-Old Woman

This 26-year-old woman with a testosterone level of 72 ng/dL requires a comprehensive endocrine workup to exclude potentially serious conditions including androgen-secreting tumors, PCOS, and other endocrinopathies, as this level is moderately elevated and warrants systematic investigation regardless of symptom severity. 1

Initial Assessment Priority

The testosterone level of 72 ng/dL is moderately elevated (normal upper limit ~50-60 ng/dL in most labs). While PCOS is statistically most likely, you must systematically exclude life-threatening conditions first 1.

Critical Clinical Features to Assess Immediately

Look specifically for these red flags that change management urgency:

• Virilization signs: clitoromegaly, increased muscularity, deepening voice, male-pattern baldness
• Rapid onset or progression: symptoms developing over weeks to months (suggests tumor)
• Palpable abdominal or pelvic mass
• Menstrual pattern: amenorrhea, oligomenorrhea, or regular cycles
• PCOS features: central obesity, acanthosis nigricans, acne, seborrhea, hirsutism
• Medication history: anabolic steroids, valproic acid, danazol 1

Common pitfall: Testosterone levels in the 70s ng/dL range can occur with both benign (PCOS) and malignant conditions. The clinical presentation, not just the number, guides urgency 2, 3.

Required Laboratory Workup

Order these tests immediately 1:

First-Tier Essential Tests:

• Repeat early morning (7-9 AM) total testosterone on days 4-10 of menstrual cycle if cycling regularly
• Free testosterone (send to specialty/reference laboratory—commercial lab assays are notoriously unreliable) 4
• DHEA-S: If >600-700 µg/dL, strongly suggests adrenal tumor requiring urgent CT abdomen 5, 3
• 17-hydroxyprogesterone (early morning, follicular phase): Screen for non-classic congenital adrenal hyperplasia, especially if Ashkenazi Jewish, Hispanic, or Slavic ethnicity 1
• Pregnancy test if amenorrheic
• Prolactin: Exclude hyperprolactinemia
• TSH: Thyroid dysfunction can affect androgen metabolism

Important Laboratory Caveat

Commercial testosterone assays show massive variability—the same sample can read 71.8 ng/dL in one lab and 123.4 ng/dL in another 4. Use a specialty endocrine laboratory for free testosterone measurement, not a standard commercial lab. Most hyperandrogenic women have testosterone >50 ng/dL, while most normal women are <40 ng/dL 4.

Imaging Studies Required

Pelvic ultrasound (transvaginal if sexually active):

• Detect ovarian neoplasm or polycystic ovarian morphology
• Critical point: Small androgen-secreting tumors (Leydig cell, steroid cell tumors) may not be visible on standard imaging 2, 6, 7

Do NOT order abdominal CT initially unless DHEA-S is markedly elevated (>600-700 µg/dL), suggesting adrenal source 5, 3.

Diagnostic Algorithm Based on Results

If DHEA-S >600-700 µg/dL:

• Urgent abdominal CT/MRI to evaluate for adrenal adenoma or carcinoma
• Refer to endocrinology immediately 5, 3

If Testosterone Remains Elevated with Normal DHEA-S:

Most likely diagnosis is ovarian source (PCOS most common, but must exclude tumor) 1:

1. Assess for PCOS criteria:

   • Menstrual irregularity/anovulation
   • Clinical or biochemical hyperandrogenism
   • Polycystic ovaries on ultrasound
   • Exclude other causes

2. If PCOS features present AND no red flags: Likely PCOS—proceed with metabolic screening (fasting glucose, lipids, consider oral glucose tolerance test) 1

3. If rapid progression, virilization, or testosterone >150 ng/dL: Consider androgen-secreting tumor or ovarian hyperthecosis 3, 8, 9

   • May require GnRH agonist suppression test: >50% suppression suggests LH-dependent ovarian source (hyperthecosis or functional) vs. autonomous tumor 8, 9
   • If imaging negative but high suspicion: Selective ovarian venous catheterization may be needed 3
   • Consider diagnostic laparoscopy if clinical suspicion high despite negative imaging 6, 7

Additional Testing if Clinically Indicated:

• Cushing's syndrome screening: If cushingoid features present (1 mg dexamethasone suppression test or 24-hour urinary free cortisol)
• Acromegaly screening: If acromegalic features (IGF-1)
• Androstenedione: May be elevated when testosterone is borderline 5

Management Approach

If PCOS Diagnosed:

• Combined oral contraceptive pills (first-line for non-fertility seeking patients)
• Metformin if metabolic syndrome/insulin resistance present
• Spironolactone for hirsutism (after 6 months, effects maximal at 9 months) 1
• Lifestyle modification for weight management

If Ovarian Hyperthecosis Suspected:

• GnRH agonist therapy with add-back hormone replacement 8, 9
• Monitor response clinically and biochemically
• Bilateral oophorectomy reserved for refractory cases or if fertility not desired

If Tumor Suspected or Confirmed:

• Surgical resection (definitive treatment)
• Expect testosterone normalization within 24 hours post-operatively 2

Critical Pitfalls to Avoid

1. Don't rely on "normal" reference ranges from commercial labs—they're often 10-90 ng/dL but don't distinguish normal from hyperandrogenic women 4

2. Don't dismiss elevated testosterone without imaging—even small tumors can produce significant androgens and may not be visible on initial imaging 2, 6, 7

3. Don't assume PCOS without excluding other causes—the workup exists because 0.2% of hyperandrogenic women have tumors, over half malignant 1

4. Don't forget timing matters—testosterone should be drawn early morning, follicular phase in cycling women 1

5. Beware of discordance between labs and clinical picture—if testosterone is very elevated but no virilization, consider laboratory interference and request diethyl ether extraction 2